As noted earlier, upregulation of Sp7 in breast cancer cells is associated with increased invasion and bone metastasis, and this may occur by upregulation of ECM modifying metalloproteinases, MMP9 and MMP13, and other factors that increase vascularization, and affect bone cell function (Yao et al., 2019). The gene discussed is SP7; the disease is breast carcinoma.